Magnetic Drug Targeting: Developing the Basics

dc.contributor.advisorShapiro, Benjaminen_US
dc.contributor.authorNacev, Aleksandar Nelsonen_US
dc.contributor.departmentBioengineeringen_US
dc.contributor.publisherDigital Repository at the University of Marylanden_US
dc.contributor.publisherUniversity of Maryland (College Park, Md.)en_US
dc.date.accessioned2013-07-04T05:31:48Z
dc.date.available2013-07-04T05:31:48Z
dc.date.issued2013en_US
dc.description.abstractFocusing medicine to disease locations is a needed ability to treat a variety of pathologies. During chemotherapy, for example, typically less than 0.1% of the drugs are taken up by tumor cells, with the remaining 99.9% going into healthy tissue. Physicians often select the dosage by how much a patient can physically withstand rather than by how much is needed to kill all the tumor cells. The ability to actively position medicine, to physically direct and focus it to specific locations in the body, would allow better treatment of not only cancer but many other diseases. Magnetic drug targeting (MDT) harnesses therapeutics attached to magnetizable particles, directing them to disease locations using magnetic fields. Particles injected into the vasculature will circulate throughout the body as the applied magnetic field is used to attempt confinement at target locations. The goal is to use the reservoir of particles in the general circulation and target a specific location by pulling the nanoparticles using magnetic forces. This dissertation adds three main advancements to development of magnetic drug targeting. Chapter 2 develops a comprehensive ferrofluid transport model within any blood vessel and surrounding tissue under an applied magnetic field. Chapter 3 creates a ferrofluid mobility model to predict ferrofluid and drug concentrations within physiologically relevant tissue architectures established from human autopsy samples. Chapter 4 optimizes the applied magnetic fields within the particle mobility models to predict the best treatment scenarios for two classes of chemotherapies for treating future patients with hepatic metastatic breast cancer microtumors.en_US
dc.identifier.urihttp://hdl.handle.net/1903/14276
dc.subject.pqcontrolledBiomedical engineeringen_US
dc.subject.pquncontrolledblood vesselen_US
dc.subject.pquncontrolledbreast canceren_US
dc.subject.pquncontrolleddynamic magnetic shiften_US
dc.subject.pquncontrolledmagnetic drug targetingen_US
dc.subject.pquncontrolledmetastasesen_US
dc.subject.pquncontrollednanoparticleen_US
dc.titleMagnetic Drug Targeting: Developing the Basicsen_US
dc.typeDissertationen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Nacev_umd_0117E_14123.pdf
Size:
8.62 MB
Format:
Adobe Portable Document Format